The Choice of Protamine Sulfate Dosing Regimen for Coronary Artery Bypass Graft Surgery

Changes in hemodynamics and coagulation hemostasis during the use of protamine sulfate to neutralize heparin in a ratio of 0.5:1 in coronary artery bypass graft surgery have been studied. A comparative analysis of hemodynamic abnormalities, postoperative blood loss, and the need for blood transfusio...

Full description

Bibliographic Details
Main Authors: Andriy P. Mazur, Artur V. Gabriyelyan, Pavlo V. Hurin, Maksim M. Babich, Vladyslav V. Antonenko, Vladyslav S. Shevelukha
Format: Article
Language:English
Published: Professional Edition Eastern Europe 2022-06-01
Series:Український журнал серцево-судинної хірургії
Subjects:
Online Access:http://cvs.org.ua/index.php/ujcvs/article/view/485
_version_ 1811229946092191744
author Andriy P. Mazur
Artur V. Gabriyelyan
Pavlo V. Hurin
Maksim M. Babich
Vladyslav V. Antonenko
Vladyslav S. Shevelukha
author_facet Andriy P. Mazur
Artur V. Gabriyelyan
Pavlo V. Hurin
Maksim M. Babich
Vladyslav V. Antonenko
Vladyslav S. Shevelukha
author_sort Andriy P. Mazur
collection DOAJ
description Changes in hemodynamics and coagulation hemostasis during the use of protamine sulfate to neutralize heparin in a ratio of 0.5:1 in coronary artery bypass graft surgery have been studied. A comparative analysis of hemodynamic abnormalities, postoperative blood loss, and the need for blood transfusion in patients receiving protamine sulfate at the above dose has been carried out. The study included 70 patients who were successively operated on at the Shalimov National Institute of Surgery and Transplantation due to coronary heart disease, in whom coronary artery bypass grafting was performed on a working heart. The study group included 30 patients in whom heparin was neutralized with protamine in a ratio of 1:0.5. The comparison group included patients in whom heparin was neutralized with protamine in a ratio of 1:1. Statistical processing of the material was performed using the software StatPlus professional 2007. Both parametric and non-parametric methods of statistical analysis were used. The parametric method (Student’s t-test) was used to test the hypothesis of the equality of the mean values of two samples from different general sets. Pearson’s criterion was used to compare the two sets by qualitative features. Statistically significant differences in the obtained results were considered at p <0.05, which indicated a 95% probability of discrepancies. Changes in blood pressure, central venous pressure, electrocardiogram, cardiac output, cardiac index, coagulogram, complete blood count, biochemical blood test, electrolyte, acid-base and gas composition of blood during surgery and in the postoperative period were analyzed. The results showed that reduction in the dose of protamine to neutralize heparin is effective and safe in patients undergoing coronary artery bypass grafting. However, changes in hemodynamics and coagulogram in patients treated with 50% protamine dose were insignificant and did not increase perioperative blood loss and blood transfusion needs.
first_indexed 2024-04-12T10:21:45Z
format Article
id doaj.art-a9f23e496b814b6ab0633da9ad44a79f
institution Directory Open Access Journal
issn 2664-5963
2664-5971
language English
last_indexed 2024-04-12T10:21:45Z
publishDate 2022-06-01
publisher Professional Edition Eastern Europe
record_format Article
series Український журнал серцево-судинної хірургії
spelling doaj.art-a9f23e496b814b6ab0633da9ad44a79f2022-12-22T03:37:05ZengProfessional Edition Eastern EuropeУкраїнський журнал серцево-судинної хірургії2664-59632664-59712022-06-01302222610.30702/ujcvs/22.30(02)/MG017-2226485The Choice of Protamine Sulfate Dosing Regimen for Coronary Artery Bypass Graft SurgeryAndriy P. Mazur0https://orcid.org/0000-0002-6873-7573Artur V. Gabriyelyan1https://orcid.org/0000-0002-4141-5902Pavlo V. Hurin2https://orcid.org/0000-0002-2234-1258Maksim M. Babich3https://orcid.org/0000-0002-7272-8688Vladyslav V. Antonenko4https://orcid.org/0000-0003-2395-4563Vladyslav S. Shevelukha5https://orcid.org/0000-0002-9520-9290National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, UkraineShalimov’s National institute of Surgery and Transplantation, Kyiv, UkraineShalimov’s National institute of Surgery and Transplantation, Kyiv, UkraineShalimov’s National institute of Surgery and Transplantation, Kyiv, UkraineShalimov’s National institute of Surgery and Transplantation, Kyiv, UkraineShalimov’s National institute of Surgery and Transplantation, Kyiv, UkraineChanges in hemodynamics and coagulation hemostasis during the use of protamine sulfate to neutralize heparin in a ratio of 0.5:1 in coronary artery bypass graft surgery have been studied. A comparative analysis of hemodynamic abnormalities, postoperative blood loss, and the need for blood transfusion in patients receiving protamine sulfate at the above dose has been carried out. The study included 70 patients who were successively operated on at the Shalimov National Institute of Surgery and Transplantation due to coronary heart disease, in whom coronary artery bypass grafting was performed on a working heart. The study group included 30 patients in whom heparin was neutralized with protamine in a ratio of 1:0.5. The comparison group included patients in whom heparin was neutralized with protamine in a ratio of 1:1. Statistical processing of the material was performed using the software StatPlus professional 2007. Both parametric and non-parametric methods of statistical analysis were used. The parametric method (Student’s t-test) was used to test the hypothesis of the equality of the mean values of two samples from different general sets. Pearson’s criterion was used to compare the two sets by qualitative features. Statistically significant differences in the obtained results were considered at p <0.05, which indicated a 95% probability of discrepancies. Changes in blood pressure, central venous pressure, electrocardiogram, cardiac output, cardiac index, coagulogram, complete blood count, biochemical blood test, electrolyte, acid-base and gas composition of blood during surgery and in the postoperative period were analyzed. The results showed that reduction in the dose of protamine to neutralize heparin is effective and safe in patients undergoing coronary artery bypass grafting. However, changes in hemodynamics and coagulogram in patients treated with 50% protamine dose were insignificant and did not increase perioperative blood loss and blood transfusion needs.http://cvs.org.ua/index.php/ujcvs/article/view/485heparinprotaminehemodynamicsperioperative blood lossblood transfusionhemostasis
spellingShingle Andriy P. Mazur
Artur V. Gabriyelyan
Pavlo V. Hurin
Maksim M. Babich
Vladyslav V. Antonenko
Vladyslav S. Shevelukha
The Choice of Protamine Sulfate Dosing Regimen for Coronary Artery Bypass Graft Surgery
Український журнал серцево-судинної хірургії
heparin
protamine
hemodynamics
perioperative blood loss
blood transfusion
hemostasis
title The Choice of Protamine Sulfate Dosing Regimen for Coronary Artery Bypass Graft Surgery
title_full The Choice of Protamine Sulfate Dosing Regimen for Coronary Artery Bypass Graft Surgery
title_fullStr The Choice of Protamine Sulfate Dosing Regimen for Coronary Artery Bypass Graft Surgery
title_full_unstemmed The Choice of Protamine Sulfate Dosing Regimen for Coronary Artery Bypass Graft Surgery
title_short The Choice of Protamine Sulfate Dosing Regimen for Coronary Artery Bypass Graft Surgery
title_sort choice of protamine sulfate dosing regimen for coronary artery bypass graft surgery
topic heparin
protamine
hemodynamics
perioperative blood loss
blood transfusion
hemostasis
url http://cvs.org.ua/index.php/ujcvs/article/view/485
work_keys_str_mv AT andriypmazur thechoiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery
AT arturvgabriyelyan thechoiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery
AT pavlovhurin thechoiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery
AT maksimmbabich thechoiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery
AT vladyslavvantonenko thechoiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery
AT vladyslavsshevelukha thechoiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery
AT andriypmazur choiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery
AT arturvgabriyelyan choiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery
AT pavlovhurin choiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery
AT maksimmbabich choiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery
AT vladyslavvantonenko choiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery
AT vladyslavsshevelukha choiceofprotaminesulfatedosingregimenforcoronaryarterybypassgraftsurgery